$4,050.89 travel Payment -- AbbVie Inc to Dr. James Wilson

AbbVie Inc. covers $4,050.89 in travel and lodging for Oncology-related Farxiga engagement.

This page provides a detailed analysis of a $4,050.89 travel payment from AbbVie Inc to Dr. James Wilson. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$4,050.89
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyAbbVie Inc
PhysicianDr. James Wilson
NPI Number1024638695
Physician SpecialtyOncology
LocationSacramento, CA
Date of Payment2025-08-18
Related Drug/DeviceFarxiga
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AbbVie Inc made a $4.1K travel payment to James Wilson, a Oncology specialist in Sacramento, CA. The payment was associated with Farxiga. AbbVie Inc. paid $4,050.89 for travel and lodging expenses related to Farxiga. The payment was made to Dr. James Wilson, an Oncologist in Sacramento, CA. This payment occurred on August 18, 2025.

Patient Guidance: What This Payment Means for You

This payment covered travel and lodging expenses for a healthcare professional involved with a specific medication. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry, particularly for educational events or consultations related to specific drugs like Farxiga, and the amount appears moderate for such purposes.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act provisions of the Affordable Care Act, requiring disclosure of payments made by manufacturers of drugs, devices, and medical supplies to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.1K payment for?

This was a travel payment of $4.1K from AbbVie Inc to James Wilson, categorized as "Travel and Lodging". It was associated with Farxiga. The payment was reported under the Sunshine Act (CMS Open Payments).

Does James Wilson accept pharmaceutical money?

Yes, James Wilson received this $4.1K payment from AbbVie Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view James Wilson's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.1K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Oncology?

To compare this payment against Oncology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Oncology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about James Wilson's relationship with AbbVie Inc?

The payment specifically covers 'Travel and Lodging'. This $4.1K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Oncology?

The associated drug is Farxiga, a medication.

What should patients do after learning about this payment?

This payment covered travel and lodging expenses for a healthcare professional involved with a specific medication.

What else should I know about this travel payment?

The recipient is a physician in Oncology.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.